Dr. Chilvana V. Patel, MD

Dr. Patel practices at John Sealy Hospital in Galveston, Texas, part of The University of Texas System.

Dr. Patel's NPI, 1013178714, was assigned on June 24, 2008. Dr. Patel graduated from N.H.L Municipal Medical College in 2004. Dr. Patel's New York license number on file is 263873.

Dr. Patel's primary practice is John Sealy Hospital, at 301 University Boulevard, Galveston, TX 77555 in Galveston County. The practice phone is (409) 772-1011.

Dr. Patel's primary practice is John Sealy Hospital in Galveston, Texas, part of The University of Texas System. The medical group on file is UTMB Faculty Group Practice.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patel practices. Vendor and product names are available with a free account.

Neurology is Dr. Patel's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Patel is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Patel's licenses on file in 2 states: New York and Texas.

Dmand AI lists acute mini-stroke (TIA), epilepsy, fibromyalgia and chronic pain, lower back pain, migraine and chronic headache, muscle weakness, neuropathy and thoracic spine disorders among the conditions Dr. Patel treats.

CMS data shows 133 Medicare services from Dr. Patel across 6 procedure codes in 2024, for 110 Medicare patients. Medicare paid $5,106 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 110 Medicare patients who saw Dr. Patel in 2024. The largest group is 65 to 74, with 46 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Patel's median patient age at 68, with 65% women.

In 2024, Dr. Patel wrote 154 Medicare Part D claims for 51 patients. 79% of them were for generic drugs. CMS names the drug for 31 of them, across 2 drugs with 11 or more claims each, at $539 in total drug cost. In 2023, CMS named 60 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Patel for performance year 2024, reported as part of a group. Dr. Patel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 14 papers to Dr. Patel, published from 2019 to 2025. 2023 was the busiest year, with 6. Dr. Patel has published most often in Cureus. Dr. Patel's most frequent co-authors are Xiangping Li, MD, Anand Vilaschandra Patel, MD and Xiang Fang, MD, PhD.

CMS Open Payments shows 108 general payments to Dr. Patel from 13 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $849.

Dmand AI lists 1 award for Dr. Patel, most recently CMS Stage 1 EHR in 2013.

Dr. Patel graduated from N.H.L Municipal Medical College in 2004.

Dr. Patel is in network with 21 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.